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Methylaluminoxane as an Alternative for BArF in the Iridium-Catalyzed
Asymmetric Hydrogenation of Imines
Natasˇa Mrsˇic´,[a] Lavinia Panella,[b] Edwin G. IJpeij,[b] Adriaan J. Minnaard,*[a] Ben L. Feringa,*[a] and
Johannes G. de Vries*[a, b]
One of the methods for the preparation of enantiopure secon-
dary amines is the asymmetric hydrogenation of imines. Over
the last two decades, chiral catalysts based on iridium, rhodi-
um, ruthenium, palladium, and titanium have been reported to
be effective in the hydrogenation of C=N functionalities.[1]
Recently, we have published our results on the asymmetric
hydrogenation of N-aryl imines using an iridium catalyst based
on the use of the phosphoramidite ligand PipPhos L1 and the
BArF counterion.[2] In the hydrogenation of N-(3,5-dimethyl-
phenyl)-(1-phenyl-ethylidene)-amine 1, full conversion over 4 h
and >99% ee was achieved. Using a catalyst precursor that
contained chloride as counter ion, the reaction was much
slower and needed higher temperatures and higher pressures
to reach full conversion. In addition, the product was isolated
with lower enantioselectivity. This underscores the importance
of BArF as counter ion in this type of asymmetric hydrogena-
tion.[3] In many hydrogenations the BArF counterion outper-
formed the PF6 counterion, which is attributed to its steric
bulk.[3c]
Phosphoramidites are cheap ligands that are easily made in
only two synthetic steps.[4] They have found many applications
in asymmetric hydrogenation.[5] However, the BArF counter ion
is very expensive, which could hinder the industrial application
of imine hydrogenation with Ir/PipPhos.
In olefin polymerization, the common metallocene halide
catalysts are made cationic by reaction with a large excess of
methylaluminoxane (MAO).[5] MAO is a poorly-defined oligo-
meric material roughly characterized by the formula
(Al(CH3)xOy)n. MAO alkylates and then activates the metal-chlo-
ride pre-catalyst species by abstracting the chloride, thus form-
ing an ion pair. It is prepared by a controlled hydrolysis of tri-
methylaluminium (TMA) and it always contains small amounts
of TMA. TMA is a methylating agent and for that reason it is
often removed by reaction with a bulky phenol, with which it
forms AlMe(OAr)2. Although a large excess of MAO is necessary
in these polymerizations, the low cost and the innocuous
nature of this compound makes this procedure very attractive
as a potential replacement of BArF in asymmetric hydrogena-
tion reactions. In addition, in view of its oligomeric nature
MAO can be viewed as a “bulky” anion.
For these reasons the use of MAO was explored in combina-
tion with an iridium chloride catalyst precursor in the asym-
metric hydrogenation of imines using PipPhos (L1) and the
phosphine-oxazoline L2[3b,6] developed by Pfaltz as ligands
(Scheme 1). Two imine substrates were chosen, N-aryl imine 1
and cyclic imine 2. The hydrogenations were performed using
2.5 mol% of [{Ir(COD)Cl}2] at room temperature and 0.5 MPa of
hydrogen pressure. Two different ligands were used, phosphor-
amidite (S)-PipPhos L1 and commercially available phosphi-
nooxazoline ligand L2. To remove traces of TMA from MAO,
bulky phenol 3 was used in half of the experiments.
Two different concentrations of the MAO solution were em-
ployed and three different amounts were screened (5, 50, and
500 equivalents with respect to [{Ir(COD)Cl}2]). Catalysts were
prepared in a glovebox and the hydrogenation was performed
at 0.5 MPa H2 pressure in a Premex 96-Multi Reactor (96 reac-
tion vessels). Solutions of MAO were dispersed by a liquid dis-
pensing robot into the vials, optionally followed by the addi-
tion of a solution of the bulky phenol 3. The substrate solution
was then added, followed by the addition of the catalyst (pre-
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Scheme 1. Iridium catalyzed asymmetric hydrogenation of 1 and 2 using
MAO as a counterion.
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mixed solution of [{Ir(COD)Cl}2] and ligand). Hydroge-
nation was carried out over 16 h.
Using 5 equivalents of MAO, with respect to the
metal precursor, modest conversions were achieved
suggesting that the dehalogenation of the iridium
catalyst was not complete. However, when 50 equiva-
lents of MAO were used, high conversions were
achieved with both substrates (Table 1). Although no
duplicates were performed, we see a good correla-
tion between the results with MAO A (1.5m in tolu-
ene) and MAO B (2.3m in hexane), which differ only
in the nature of the solvent, particularly when phenol
3 was used. High enantioselectivity was achieved in
the hydrogenation of N-aryl imine 1 using phosphi-
nooxazoline L2 in dichloromethane, without the use
of phenol (98% yield, 76% ee). The same substrate
was hydrogenated in the presence of PipPhos (L1)
and phenol in toluene with up to 45% ee in 98%
yield. In the case of dihydroisoquinoline 2, the best
result was achieved by using PipPhos L1 and phenol
in toluene (87% yield, 32% ee). When ligand L2 was
employed on the same substrate, without phenol in
toluene, only 12% yield and 24% ee was reached.
Using 500 equivalents of MAO, yields of the de-
sired product were mostly very low, especially of the
cyclic imine 2 (Table 2). In the cases where there was
no product observed, the starting material was also
decomposed. This is particularly prevalent in the ab-
sence of 3. Thus we assume that with these large
amounts of MAO methylation of the imines occurs.
The highest enantioselectivity was obtained in the
hydrogenation of N-aryl imine 1 using phosphinooxa-
zoline ligand L2 in dichloromethane, without the
presence of phenol (89% ee, 40% conversion). In the
hydrogenation of the same substrate using L1 the
best result was achieved by using dichloromethane
and in the presence of 3 (35% ee, 82% conv.) Dihy-
droisoquinoline 2 was hydrogenated with up to 84%
ee (70% conversion) in dichloromethane with ligand
L2, with addition of 3. The use of L1 in the hydroge-
nation of the cyclic imine 2 led to formation of 2a in
47% yield and 47% ee in the presence of 3.
To gather experimental evidence for the cationic
nature of the iridium complex after addition of MAO,
we first treated [{Ir(COD)Cl}2] with 2 equiv of L2 in
CDCl3 to obtain a single complex for which we
assume structure A. The 31P NMR spectra of the neu-
tral complex A showed a single peak at d=
15.8 ppm. Treatment of A with 50 equiv of MAO in
toluene gave a new complex which we assume to be
the cationic square planar complex B (Scheme 2).
This complex also showed a single peak in the
31P NMR spectra at d=17.4 ppm. This compares very
well with the [Ir(L2)(COD)]BArF complex, to which
the peak at d=17.2 ppm is attributed. Even more
significant, were the changes in the 1H NMR spectra.
Whereas complex A shows two broad absorptions
Table 1. Asymmetric hydrogenation of imines using iridium catalysts and 50 equiva-
lents of MAO.[a,b]
Yield of amine[c] [%] 50 Equivalents
MAO A MAO B
Phenol Solvent Substrate Ir/L1 Ir/L2 Ir/L1 Ir/L2
with 3
CH2Cl2 1 98 98 99 99
CH2Cl2 2 85 20 95 19
toluene 1 98 98 98 98
toluene 2 74 12 87 9
without 3
CH2Cl2 1 98 98 99 5
CH2Cl2 2 95 15 97 12
toluene 1 – 98 81 99
toluene 2 11 5 94 12
Selectivity ee[d] [%] 50 Equivalents
MAO A MAO B
Phenol Solvent Substrate Ir/L1 Ir/L2 Ir/L1 Ir/L2
with 3
CH2Cl2 1 40 60 40 66
CH2Cl2 2 30 12 26 16
toluene 1 38 48 45 57
toluene 2 6 14 32 10
without 3
CH2Cl2 1 18 76 37 –
CH2Cl2 2 15 10 14 15
toluene 1 – 59 42 70
toluene 2 27 12 4 24
[a] Reaction conditions: 100 mmol imine, 2.5 mmol [{Ir(COD)Cl}2] , 10 mmol (S)-PipPhos
L1, 125 mmol MAO, 250 mmol phenol 3, solvent, RT, 0.5 MPa H2, 16 h. [b] 100 mmol
imine, 2.5 mmol [{Ir(COD)Cl}2] , 5 mmol L2, 125 mmol MAO, 250 mmol phenol 3, 2.45 mL
of solvent, RT, 0.5 MPa H2, 16 h. [c] Yield was determined by GC and HPLC. [d] Enantio-
meric excess was determined by HPLC.[e]MAO A=1.5m in toluene, MAO B=2.3m in
heptane.
Table 2. Asymmetric hydrogenation of imines using iridium catalysts and 500 equiva-
lents of MAO.[a,b]
Yield of amine[c] [%] 500 Equivalents
MAO A MAO B
Phenol Solvent Substrate Ir/L1 Ir/L2 Ir/L1 Ir/L2
with 3
CH2Cl2 1 82 81 94 95
CH2Cl2 2 0 0 47 70
toluene 1 82 83 95 94
toluene 2 0 0 0 32
without 3
CH2Cl2 1 3 2 13 40
CH2Cl2 2 0 0 0 0
toluene 1 5 3 17 48
toluene 2 0 0 0 0
Selectivity ee[d] [%] 500 equivalents
MAO A MAO B
Phenol Solvent Substrate Ir/L1 Ir/L2 Ir/L1 Ir/L2
with 3
CH2Cl2 1 35 15 30 60
CH2Cl2 2 – – 47 84
toluene 1 11 21 5 51
toluene 2 – – – 66
without 3
CH2Cl2 1 – – – 89
CH2Cl2 2 – – – –
toluene 1 – – – 65
toluene 2 – – – –
[a] Reaction conditions: 100 mmol imine, 2.5 mmol [{Ir(COD)Cl}2] , 10 mmol (S)-PipPhos
L1, 1250 mmol MAO, 2500 mmol phenol 3, solvent, RT, 0.5 MPa H2, 16 h. [b] 100 mmol
imine, 2.5 mmol [{Ir(COD)Cl}2] , 5 mmol L2, 1250 mmol MAO, 2500 mmol phenol 3,
2.45 mL of solvent, RT, 0.5 MPa H2, 16 h. [c] Yield was determined by GC and HPLC.
[d] Enantiomeric excess was determined by HPLC. [e] MAO A=1.5m in toluene,
MAO B=2.3m in heptane.
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for the olefinic COD protons at d=4.04 and 3.85 ppm, in com-
plex B all 4 vinylic protons show separate resonances at d=
5.27, 5.15, 3.55, and 3.35 ppm. This again, compares very well
with the BArF complex for which these absorptions are at d=
5.13, 5.02, 3.40, and 3.13 ppm, confirming that both are square
planar complexes. In addition, the resonance for the proton at
C-4 of the oxazolidine moves from d=4.60 ppm in A to d=
4.50 ppm in B, whereas in the BArF complex this is d=
4.45 ppm.
Analysis of these results reveals that MAO is an interesting
substitute for the expensive BArF counterion in the asymmetric
hydrogenation of imines although the ratio of MAO to iridium
needs careful adjustment. In the present case 50 equivalents
gave the best results in terms of rate, but more work is
needed to establish the true optimum ratio. It is clear that in
industrial applications, the iridium catalyst will be used at less
than 0.1 mol%, which translates to a mere 5 mol% of MAO.
The rate of the hydrogenation with 50 equivalents is some-
what lower than the rate obtained in the BArF reaction; how-
ever, it is much faster than using the chloride precursor with-
out MAO. The enantioselectivity of the reaction is clearly influ-
enced as well. Here, apparently the enantioselectivity increases
with increasing amount of MAO. In the hydrogenation of sub-
strate 1, 99% ee was previously obtained by using Iridium,
BArF, and PipPhos. Here we achieved a maximum of 89% ee.
Nevertheless, these are only preliminary results that show the
potential of the method. It is possible to test more variants of
MAO and indeed many modified forms of MAO and several
smaller model compounds have been reported.[6b] It may also
be possible to use other hydrolyzed trialkylaluminum com-
pounds. In this context we would also like to draw attention
to the work of Leitner and co-workers, who showed that in the
nickel-catalyzed hydrovinylation reaction BArF can be replaced
by using a combination of a halide containing pre-catalyst and
a Lewis acid. In particular indium and bismuth based Lewis
acids led to the formation of highly reactive catalysts.[8]
In conclusion, methylaluminoxane was shown to be an effi-
cient substitute for the expensive BArF counterion in iridium-
catalyzed asymmetric imine hydrogenation although the rate
of the reaction and the enantioselectivity were somewhat
lower than those obtained with BArF as counterion. We expect
that this low-cost technology will open the way to more indus-
trial applications of iridium-catalyzed asymmetric hydrogena-
tion.
Experimental Section
Solvents were anhydrous and were purchased from Fluka and Al-
drich. Dihydroisoquinoline 2 was purchased from Acros and used
without purification. Metal precursor [{Ir(COD)Cl}2] was purchased
from Strem, whereas ligand L2 was purchased from Fluka. Ligand
L1 was prepared according to the literature procedure.[9]
High throughput hydrogenations were performed in a Premex 96
autoclave. NMR spectra were measured by using Varian Gemini-
200 and Varian AMX400 spectrometers. GC analysis was performed
by using a HP6890 with a flame ionization detector (Agilent HP-5
column), whereas HPLC analysis was performed by using a Shimad-
zu LC-10ADVP HPLC equipped with a Shimadzu SPD-M10AVP
diode array detector. The enantiomeric excess was determined by
using Agilent HPLC with a chiral column (Chiralcel OD-H) in com-
parison with racemic products. Racemic amines were prepared by
reduction of the imines with sodium borohydride in ethanol. High
resolution mass spectra were recorded by using an AEI-MS-902
mass spectrometer. Optical rotations were measured by using a
Schmidt+Haensch polarimeter (Polartronic MH8) with a 10 cm cell
(c given in g per 100 mL).
General experimental procedure for the preparation of the imine 1:
A 100 mL round-bottom flask was filled with acetophenone
(5.8 mL, 50 mmol) and 3,5-dimethylaniline (7.5 mL, 60 mmol) and
molecular sieves (4 , 20 g) in toluene (30 mL). The reaction mix-
ture was stirred at room temperature overnight, filtered and the
solvent evaporated. The crude product was purified by Kugelrohr
distillation.
General procedure for the hydrogenation experiments with the
use of MAO as a counterion: Reactions were performed using
2.5 mol% of [{Ir(COD)Cl}2] (2.5 mmol, 1.67 mg) at room temperature
and 0.5 MPa of hydrogen pressure. PipPhos L1 (10 mmol, 3.99 mg)
and [{Ir(COD)Cl}2] (2.5 mmol, 1.67 mg) were dissolved in solvent
(200 mmol) and pipetted into each vial. Phosphinooxazoline ligand
L2 (5 mmol, 1.86 mg) and [{Ir(COD)Cl}2] (2.5 mmol, 1.67 mg) were
dissolved in solvent (200 mmol) and pipetted into each vial.
For 5 equiv of MAO: Phenol 3 (25 mmol, 5.51 mg, per reaction vial),
added as a solution in DCM or toluene (100 mL, 0.055m). MAO A
(1.5m in toluene): 300 mL of MAO A was diluted with 3.30 mL of
heptane. 100 mL of solution was pipetted per reaction vial. MAO B
(2.3m in heptane): 200 mL of MAO B diluted with 3.68 mL of hep-
tane. 100 mL of solution was pipetted per each reaction vial.
For 50 equiv of MAO: Phenol 3 (250 mmol, 55.1 mg per reaction
vial), added as a solution in DCM or toluene (100 mL, 0.055m).
MAO A (1.5m in toluene): 83 mL of solution was pipetted per each
reaction vial. MAO B (2.3m in heptane): 54 mL of solution was pi-
petted per each reaction vial.
For 500 equiv of MAO: Phenol 3 (2.5 mmol, 551 mg per reaction
vial), added as a solid. MAO A (1.5m in toluene): 833 mL of solution
was pipetted per each reaction vial. MAO B (2.3m in heptane):
544 mL of solution was pipetted per each reaction vial.
Substrates were added as a solution in DCM or toluene (100 mmol
of substrate, 2.25 mL of solvent). Solutions were pipetted in a glo-
vebox and the hydrogenation was performed in the Premex 96-
Multi Reactor with 96 reaction vessels. Solutions of MAO were dis-
pensed by using a liquid dispensing robot (Zinnser’s Lizzy) into the
vials, following by the addition of the phenol (3) solution. The sub-
strate solution was then added, followed by the addition of the
catalyst (pre-mixed solution of [{Ir(COD)Cl}2] and ligand). Hydroge-
nation was performed over 16 h at 0.5 MPa.
Scheme 2. Formation of cationic square planar iridium complex upon treat-
ment of the neutral complex A with MAO.
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N-(3,5-Dimethyl-phenyl)-(1-phenyl-ethylidene)-amine (1)[10]: Yellow
oil, 75% yield; 1H NMR (400MHz, CDCl3): d=2.25 (s, 3H), 2.34 (s,
6H), 6.44 (s, 2H), 6.75 (s, 1H), 7.44–7.48 (m, 3H), 7.96–8.0 ppm (m,
2H); 13C NMR (100MHz, CDCl3): d=18.3, 22.3, 117.9, 125.8, 128.1,
129.3, 131.3, 139.5, 140.6, 152.7, 165.9 ppm; HRMS calcd. for
C16H17N [M+1]: 223.1361; found: 223.1359.
(R)-N-(3,5-Dimethyl-phenyl)-(1-phenyl-ethyl)-amine (1a)[11]: Yellow
oil, 97% yield, >99% ee, [a]D=+12.3 (c=1.02, CHCl3) ;
1H NMR
(400MHz, CDCl3): d=1.62 (d, J=6.7 Hz, 3H), 2.32 (s, 6H), 4.02 (br,
1H), 4.61 (q, J=6.7 Hz, 1H), 6.31 (s, 2H), 6.47(s, 1H), 7.34–7.37 (m,
1H), 7.43–7.47 (m, 2H), 7.50–7.52 ppm (m, 2H); 13C NMR (100MHz,
CDCl3): d=22.4, 25.8, 54.2, 112.2, 120.2, 126.8, 127.7, 129.5, 139.6,
146.4, 148.3 ppm; HRMS calcd. for C16H19N [M+1]: 225.1517; found:
225.1504. HPLC (OD-H, eluent: heptane/iPrOH=90:10, detector:
215 nm, flow rate: 0.5 mLmin1), t1=8.5 min, t2=9.0 min. Conver-
sion was determined by using GC: Agilent HP-5, initial temp. 80 8C
for 2 min, then 15 8Cmin1 to 280 8C, hold 4 min, retention times:
starting imine t=11.9 min, product t=11.5 min.
6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (2a)[12]:
White solid, 98% yield, m.p.=97.3–97.9 8C; 1H NMR (400MHz,
CDCl3): d=1.41 (d, J=6.28 Hz, 3H), 2.61–2.65 (m, 1H), 2.75–2.80
(m, 2H), 2.94–2.99 (m, 1H), 3.21–3.24 (m, 1H), 3.81 (s, 6H), 4.03 (br,
1H), 6.53 (s, 1H), 6.58 ppm (s, 1H); 13C NMR (100MHz, CDCl3): d=
23.6, 30.2, 42.5, 52.0, 56.7, 56.9, 109.9, 112.6, 127.5, 133.0, 148.2,
148.3 ppm; HPLC (OD-H, eluent: heptane/iPrOH=88:12, detector:
215 nm, flow rate: 0.5 mLmin1), t1=23.5 min, t2=28.3 min.
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